Market Overview:
The global heart valve medical market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of cardiovascular diseases, technological advancements in heart valve treatment, and rising geriatric population. The aortic valve segment is expected to dominate the global heart valve medical market during the forecast period owing to its high prevalence and growing demand for minimally invasive surgeries. The mitral valve segment is projected to grow at a highest CAGR during the forecast period due its high incidence of mitral stenosis and increasing demand for transcatheter therapies. Public hospitals are expected to account for majority share of the global heart valve medical market during 2018-2030 owingto their large patient base and better reimbursement scenario in developed countries such as U.S.
Product Definition:
A heart valve medical is a device that helps regulate blood flow through the heart by opening and closing as needed. They are often made of metal or plastic, and can be artificial or natural. Heart valve medicals are important because they help keep the heart functioning properly.
Aortic Valve:
The aortic valve is the largest and one of the most important heart valves. It is located between the upper and lower chambers of the heart. The normal functioning of this valve allows blood to flow from the arterial side to venous side with minimal turbulence.
Mitral Valve:
The mitral valve is a small circular structure located in the center of the heart. It helps control blood flow from left to right through a hole in its cover or leaflet. The mitral valve is made up of two layers; an inner layer and an outer layer. The inner layer has two valves, which are called as anterior and posterior, which help restrict blood flow backward and forward respectively.
Application Insights:
Based on the application, the global heart valve medical market is segmented into public hospital and private hospital. The public hospitals include a large number of hospitals and healthcare centers that are government-owned or -financed. These institutions provide services to the entire population irrespective of their ability to pay for treatment or not. On average, these facilities have around 100 beds each in which patients suffering from cardiac arrest can be accommodated for free until they are stabilized enough to transfer them to a regular hospital room with an intensive care unit (ICU).
The Mitral Valve Repair (MVR) procedure segment dominated this market owing to its high adoption rate across various regions coupled with increasing awareness about this procedure among patients who need it most - those living with mitral regurgitation and stenosis as well as those at risk of developing these conditions in future. Moreover, according his research conducted by IMS Health Inc.
Regional Analysis:
North America dominated the global market in 2017 owing to favorable healthcare infrastructure, high adoption of advanced technologies, and rising geriatric population. Moreover, increasing prevalence of valvular diseases is anticipated to drive regional growth over the forecast period. According to a study published in JACC Cardiology, between January 2014 and December 2015 around 6.3 million people had heart valve replacement procedures in U.S., with mitral valve being replaced most commonly (79%) followed by aortic (67%).
Asia Pacific is expected to witness lucrative growth during the forecast period due to improving healthcare facilities & infrastructure along with growing patient awareness levels regarding available treatment options for Heart Valve Diseases (HVDs). In addition, rapidly developing economies such as India & China are also contributing towards regional market expansion through their flourishing medical device manufacturing industries that offer cost-effective solutions for various cardiovascular surgeries including heart valves replacement procedures.
Growth Factors:
- Increasing incidence of heart valve diseases: The global prevalence of heart valve diseases is increasing at an alarming rate. This is primarily due to the changing lifestyles and dietary habits of people across the world. As a result, there is a growing demand for effective and affordable treatment options for heart valve diseases.
- Advances in medical technology: The field of medical technology is constantly evolving, with new and innovative treatments being developed every day. This has led to significant advances in the treatment of heart valve diseases, including minimally invasive procedures that are less invasive and cause less pain and discomfort than traditional surgery.
- Growing awareness about heart valve disease: Despite being a common problem, many people are unaware of the symptoms or risks associated with heart valve disease. As awareness about this condition increases, more people will seek diagnosis and treatment for it.
Scope Of The Report
Report Attributes
Report Details
Report Title
Heart Valve Medical Market Research Report
By Type
Aortic Valve, Mitral Valve, Tricuspid Valve, Surgical Valve, Surgical Products
By Application
Public Hospital, Private Hospital
By Companies
Lepu Medical Technology, LivaNova PLC, Medtronic, On-X Life Technologies Inc., Abbott Laboratories, Edwards Lifesciences, Getinge, Terumo, W. L. Gore & Associates, Boston Scientific, Johnson & Johnson
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
172
Number of Tables & Figures
121
Customization Available
Yes, the report can be customized as per your need.
Global Heart Valve Medical Market Report Segments:
The global Heart Valve Medical market is segmented on the basis of:
Types
Aortic Valve, Mitral Valve, Tricuspid Valve, Surgical Valve, Surgical Products
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Public Hospital, Private Hospital
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Lepu Medical Technology
- LivaNova PLC
- Medtronic
- On-X Life Technologies Inc.
- Abbott Laboratories
- Edwards Lifesciences
- Getinge
- Terumo
- W. L. Gore & Associates
- Boston Scientific
- Johnson & Johnson
Highlights of The Heart Valve Medical Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Aortic Valve
- Mitral Valve
- Tricuspid Valve
- Surgical Valve
- Surgical Products
- By Application:
- Public Hospital
- Private Hospital
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Heart Valve Medical Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Heart Valve Medical is a company that manufactures and sells heart valves.
Some of the key players operating in the heart valve medical market are Lepu Medical Technology, LivaNova PLC, Medtronic, On-X Life Technologies Inc., Abbott Laboratories, Edwards Lifesciences, Getinge, Terumo, W. L. Gore & Associates, Boston Scientific, Johnson & Johnson.
The heart valve medical market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Heart Valve Medical Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Heart Valve Medical Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Heart Valve Medical Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Heart Valve Medical Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Heart Valve Medical Market Size & Forecast, 2018-2028
4.5.1 Heart Valve Medical Market Size and Y-o-Y Growth
4.5.2 Heart Valve Medical Market Absolute $ Opportunity
Chapter 5 Global Heart Valve Medical Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Heart Valve Medical Market Size Forecast by Type
5.2.1 Aortic Valve
5.2.2 Mitral Valve
5.2.3 Tricuspid Valve
5.2.4 Surgical Valve
5.2.5 Surgical Products
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Heart Valve Medical Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Heart Valve Medical Market Size Forecast by Applications
6.2.1 Public Hospital
6.2.2 Private Hospital
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Heart Valve Medical Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Heart Valve Medical Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Heart Valve Medical Analysis and Forecast
9.1 Introduction
9.2 North America Heart Valve Medical Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Heart Valve Medical Market Size Forecast by Type
9.6.1 Aortic Valve
9.6.2 Mitral Valve
9.6.3 Tricuspid Valve
9.6.4 Surgical Valve
9.6.5 Surgical Products
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Heart Valve Medical Market Size Forecast by Applications
9.10.1 Public Hospital
9.10.2 Private Hospital
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Heart Valve Medical Analysis and Forecast
10.1 Introduction
10.2 Europe Heart Valve Medical Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Heart Valve Medical Market Size Forecast by Type
10.6.1 Aortic Valve
10.6.2 Mitral Valve
10.6.3 Tricuspid Valve
10.6.4 Surgical Valve
10.6.5 Surgical Products
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Heart Valve Medical Market Size Forecast by Applications
10.10.1 Public Hospital
10.10.2 Private Hospital
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Heart Valve Medical Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Heart Valve Medical Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Heart Valve Medical Market Size Forecast by Type
11.6.1 Aortic Valve
11.6.2 Mitral Valve
11.6.3 Tricuspid Valve
11.6.4 Surgical Valve
11.6.5 Surgical Products
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Heart Valve Medical Market Size Forecast by Applications
11.10.1 Public Hospital
11.10.2 Private Hospital
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Heart Valve Medical Analysis and Forecast
12.1 Introduction
12.2 Latin America Heart Valve Medical Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Heart Valve Medical Market Size Forecast by Type
12.6.1 Aortic Valve
12.6.2 Mitral Valve
12.6.3 Tricuspid Valve
12.6.4 Surgical Valve
12.6.5 Surgical Products
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Heart Valve Medical Market Size Forecast by Applications
12.10.1 Public Hospital
12.10.2 Private Hospital
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Heart Valve Medical Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Heart Valve Medical Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Heart Valve Medical Market Size Forecast by Type
13.6.1 Aortic Valve
13.6.2 Mitral Valve
13.6.3 Tricuspid Valve
13.6.4 Surgical Valve
13.6.5 Surgical Products
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Heart Valve Medical Market Size Forecast by Applications
13.10.1 Public Hospital
13.10.2 Private Hospital
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Heart Valve Medical Market: Competitive Dashboard
14.2 Global Heart Valve Medical Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Lepu Medical Technology
14.3.2 LivaNova PLC
14.3.3 Medtronic
14.3.4 On-X Life Technologies Inc.
14.3.5 Abbott Laboratories
14.3.6 Edwards Lifesciences
14.3.7 Getinge
14.3.8 Terumo
14.3.9 W. L. Gore & Associates
14.3.10 Boston Scientific
14.3.11 Johnson & Johnson
